{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:53:53Z","timestamp":1793436833084,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T00:00:00Z","timestamp":1475193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T00:00:00Z","timestamp":1475193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multicentric osteolysis, nodulosis and arthropathy (MONA) spectrum disorder is a rare inherited progressive skeletal disorder caused by mutations in the matrix metalloproteinase 2 (<jats:italic>MMP2<\/jats:italic>) gene. Treatment options are limited. Herein we present successful bisphosphonate therapy in three affected patients. Patients were treated with bisphosphonates (either pamidronate or zoledronate) for different time periods. The following outcome variables were assessed: skeletal pain, range of motion, bone densitometry, internal medical problems as well as neurocognitive function. Skeletal pain was dramatically reduced in all patients soon after initiation of therapy and bone mineral density increased. Range of motion did not significantly improve. One patient is still able to walk with aids at the age of 14 years. Neurocognitive development was normal in all patients. Bisphosphonate therapy was effective especially in controlling skeletal pain in MONA spectrum disorder. Early initiation of treatment seems to be particularly important in order to achieve the best possible outcome.<\/jats:p>","DOI":"10.1038\/srep34017","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T08:52:05Z","timestamp":1475225525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Bisphosphonates in multicentric osteolysis, nodulosis and arthropathy (MONA) spectrum disorder \u2013 an alternative therapeutic approach"],"prefix":"10.1038","volume":"6","author":[{"given":"Karin","family":"Pichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Karall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kotzot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steichen-Gersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"R\u00fcmmele-Waibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureane","family":"Mittaz-Crettol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wanschitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Bonaf\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Superti-Furga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scholl-B\u00fcrgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"BFsrep34017_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jhg.2014.84","volume":"59","author":"J Azzollini","year":"2014","unstructured":"Azzollini, J. et al. Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy. J Hum Genet 59, 631\u2013637 (2014).","journal-title":"J Hum Genet"},{"key":"BFsrep34017_CR2","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s00431-013-2102-8","volume":"172","author":"FC Castberg","year":"2013","unstructured":"Castberg, F. C. et al. Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review. Eur J Pediatr 172, 1657\u20131663 (2013).","journal-title":"Eur J Pediatr"},{"key":"BFsrep34017_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4274\/Jcrpe.1166","volume":"6","author":"AV Ekbote","year":"2014","unstructured":"Ekbote, A. V. et al. Patient with mutation in the matrix metalloproteinase 2 (MMP2) gene - a case report and review of the literature. J Clin Res Pediatr Endocrinol 6, 40\u201346 (2014).","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"BFsrep34017_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ajhg.2012.07.022","volume":"91","author":"BR Evans","year":"2012","unstructured":"Evans, B. R. et al. Mutation of membrane type-1 metalloproteinase, MT1-MMP, causes the multicentric osteolysis and arthritis disease Winchester syndrome. Am J Hum Genet 91, 572\u2013576 (2012).","journal-title":"Am J Hum Genet"},{"key":"BFsrep34017_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00431-009-1028-7","volume":"169","author":"F Gok","year":"2010","unstructured":"Gok, F. et al. Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene. Eur J Pediatr 169, 363\u2013367 (2010).","journal-title":"Eur J Pediatr"},{"key":"BFsrep34017_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/jhg.2010.102","volume":"55","author":"SY Jeong","year":"2010","unstructured":"Jeong, S. Y., Kim, B. Y., Kim, H. J., Yang, J. A. & Kim, O. H. A novel homozygous MMP2 mutation in a patient with Torg-Winchester syndrome. J Hum Genet 55, 764\u2013766 (2010).","journal-title":"J Hum Genet"},{"key":"BFsrep34017_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/90100","volume":"28","author":"JA Martignetti","year":"2001","unstructured":"Martignetti, J. A. et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28, 261\u2013265 (2001).","journal-title":"Nat Genet"},{"key":"BFsrep34017_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1399-0004.2006.00584.x","volume":"69","author":"C Rouzier","year":"2006","unstructured":"Rouzier, C. et al. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet 69, 271\u2013276 (2006).","journal-title":"Clin Genet"},{"key":"BFsrep34017_CR9","first-page":"175","volume":"23","author":"SA Temtamy","year":"2012","unstructured":"Temtamy, S. A. et al. A report of three patients with MMP2 associated hereditary osteolysis. Genet Couns 23, 175\u2013184 (2012).","journal-title":"Genet Couns"},{"key":"BFsrep34017_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1399-0004.2004.00402.x","volume":"67","author":"A Zankl","year":"2005","unstructured":"Zankl, A., Bonaf\u00e9, L., Calcaterra, V., Di Rocco, M. & Superti-Furga, A. Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin Genet 67, 261\u2013266 (2005).","journal-title":"Clin Genet"},{"key":"BFsrep34017_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1359\/jbmr.061013","volume":"22","author":"A Zankl","year":"2007","unstructured":"Zankl, A. et al. Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome. J Bone Miner Res 22, 329\u2013333 (2007).","journal-title":"J Bone Miner Res"},{"key":"BFsrep34017_CR12","unstructured":"Orphanet: Multicentric osteolysis nodulosis arthropathy spectrum MONA spectrum; Available at: http:\/\/www.orpha.net\/consor\/cgi-bin\/Disease_Search.php?lng=EN&data_id=22539&Disease_Disease_Search_diseaseGroup=mona&Disease_Disease_Search_diseaseType=Pat&Disease(s)\/group%20of%20diseases=Multicentric-osteolysis-nodulosis-arthropathy-spectrum--MONA-spectrum-&title=Multicentric-osteolysis-nodulosis-arthropathy-spectrum--MONA-spectrum-&search=Disease_Search_Simple. (Accessed 18th October 2015)."},{"key":"BFsrep34017_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ajmg.a.37447","volume":"170A","author":"GS Bhavani","year":"2016","unstructured":"Bhavani, G. S. et al. Clinical and mutation profile of multicentric osteolysis nodulosis and arthropathy. Am J Med Genet A 170A, 410\u2013417 (2016).","journal-title":"Am J Med Genet A"},{"key":"BFsrep34017_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1096\/fasebj.12.12.1075","volume":"12","author":"I Massova","year":"1998","unstructured":"Massova, I., Kotra, L. P., Fridman, R. & Mobashery, S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 12, 1075\u20131095 (1998).","journal-title":"FASEB J"},{"key":"BFsrep34017_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.1999.tb07672.x","volume":"878","author":"G Murphy","year":"1999","unstructured":"Murphy, G. et al. Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci 878, 25\u201339 (1999).","journal-title":"Ann N Y Acad Sci"},{"key":"BFsrep34017_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0945-053X(98)90123-8","volume":"17","author":"LB Creemers","year":"1998","unstructured":"Creemers, L. B. et al. Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol 17, 35\u201346 (1998).","journal-title":"Matrix Biol"},{"key":"BFsrep34017_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000468616","volume":"49","author":"WT Chen","year":"1996","unstructured":"Chen, W. T. Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49, 59\u201371 (1996).","journal-title":"Enzyme Protein"},{"key":"BFsrep34017_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/scbi.2000.0365","volume":"11","author":"WG Stetler-Stevenson","year":"2001","unstructured":"Stetler-Stevenson, W. G. & Yu, A. E. Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 11, 143\u2013152 (2001).","journal-title":"Semin Cancer Biol"},{"key":"BFsrep34017_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MCD.0b013e3280147187","volume":"16","author":"SR Phadke","year":"2007","unstructured":"Phadke, S. R., Ramirez, M., Difeo, A., Martignetti, J. A. & Girisha, K. M. Torg-Winchester syndrome: lack of efficacy of pamidronate therapy. Clin Dysmorphol 16, 95\u2013100 (2007).","journal-title":"Clin Dysmorphol"},{"key":"BFsrep34017_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/humu.20349","volume":"27","author":"SC Stadler","year":"2006","unstructured":"Stadler, S. C. et al. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat 27, 748\u2013759 (2006).","journal-title":"Hum Mutat"},{"key":"BFsrep34017_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-7-31","volume":"7","author":"SC Gr\u00fcnert","year":"2012","unstructured":"Gr\u00fcnert, S. C. et al. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. Orphanet J Rare Dis 7, 31 (2012).","journal-title":"Orphanet J Rare Dis"},{"key":"BFsrep34017_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ymgme.2007.11.002","volume":"93","author":"GL Arnold","year":"2008","unstructured":"Arnold, G. L. et al. A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. Mol Genet Metab 93, 363\u2013370 (2008).","journal-title":"Mol Genet Metab"},{"key":"BFsrep34017_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1546-0096-9-31","volume":"9","author":"A Al Kaissi","year":"2011","unstructured":"Al Kaissi, A. et al. The diagnosis and management of patients with idiopathic osteolysis. Pediatr Rheumatol Online J 9, 31 (2011).","journal-title":"Pediatr Rheumatol Online J"},{"key":"BFsrep34017_CR24","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel, B. S. et al. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96, 3160\u20133169 (2011).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep34017_CR25","unstructured":"OMIM #259600 MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA; Available at: http:\/\/omim.org\/entry\/259600. (Accessed 21st June 2016)."},{"key":"BFsrep34017_CR26","doi-asserted-by":"publisher","first-page":"e68154","DOI":"10.1371\/journal.pone.0068154","volume":"8","author":"DH Lovett","year":"2013","unstructured":"Lovett, D. H. et al. N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS One 8, e68154 (2013).","journal-title":"PLoS One"},{"key":"BFsrep34017_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.carpath.2008.08.001","volume":"18","author":"R Mahimkar","year":"2009","unstructured":"Mahimkar, R. et al. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. Cardiovasc Pathol 18, 253\u2013261 (2009).","journal-title":"Cardiovasc Pathol"},{"key":"BFsrep34017_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/path.850","volume":"194","author":"Y Soini","year":"2001","unstructured":"Soini, Y., Satta, J., M\u00e4\u00e4tt\u00e4, M. & Autio-Harmainen, H. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol 194, 225\u2013231 (2001).","journal-title":"J Pathol"},{"key":"BFsrep34017_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/1096-8628(20000703)93:1<5::AID-AJMG2>3.0.CO;2-Y","volume":"93","author":"SM Al-Mayouf","year":"2000","unstructured":"Al-Mayouf, S. M., Majeed, M., Hugosson, C. & Bahabri, S. New form of idiopathic osteolysis: nodulosis, arthropathy and osteolysis (NAO) syndrome. Am J Med Genet 93, 5\u201310 (2000).","journal-title":"Am J Med Genet"},{"key":"BFsrep34017_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ejhg.2008.204","volume":"17","author":"B Tuysuz","year":"2009","unstructured":"Tuysuz, B. et al. A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects. Eur J Hum Genet 17, 565\u2013572 (2009).","journal-title":"Eur J Hum Genet"},{"key":"BFsrep34017_CR31","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","volume":"119","author":"RG Russell","year":"2007","unstructured":"Russell, R. G. Bisphosphonates: mode of action and pharmacology. Pediatrics 119 Suppl 2, S150\u2013S162 (2007).","journal-title":"Pediatrics"},{"key":"BFsrep34017_CR32","doi-asserted-by":"crossref","unstructured":"Phillipi, C. A., Remmington, T. & Steiner, R. D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev CD005088 (2008).","DOI":"10.1002\/14651858.CD005088.pub2"},{"key":"BFsrep34017_CR33","first-page":"612","volume":"163","author":"MR Faber","year":"2004","unstructured":"Faber, M. R. et al. Inherited multicentric osteolysis with carpal-tarsal localisation mimicking juvenile idiopathic arthritis. Eur J Pediatr 163, 612\u2013618 (2004).","journal-title":"Eur J Pediatr"},{"key":"BFsrep34017_CR34","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1136\/ard.2005.035725","volume":"65","author":"SM Al-Mayouf","year":"2006","unstructured":"Al-Mayouf, S. M., Madi, S. M. & Bin-Abbas, B. S. Cyclic intravenous pamidronate treatment in children with nodulosis, arthropathy and osteolysis syndrome. Ann Rheum Dis 65, 1672\u20133 (2006).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep34017_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1546-0096-8-12","volume":"8","author":"SJ Lee","year":"2010","unstructured":"Lee, S. J., Whitewood, C. & Murray, K. J. Inherited multicentric osteolysis: case report of three siblings treated with bisphosphonate. Pediatr Rheumatol Online J 8, 12 (2010).","journal-title":"Pediatr Rheumatol Online J"},{"key":"BFsrep34017_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1526-4637.2004.04038.x","volume":"5","author":"JN Robinson","year":"2004","unstructured":"Robinson, J. N., Sandom, J. & Chapman, P. T. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 5, 276\u2013280 (2004).","journal-title":"Pain Med"},{"key":"BFsrep34017_CR37","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1002\/art.20591","volume":"50","author":"DH Manicourt","year":"2004","unstructured":"Manicourt, D. H., Brasseur, J. P., Boutsen, Y., Depreseux, G. & Devogelaer, J. P. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheum 50, 3690\u20133697 (2004).","journal-title":"Arthritis Rheum"},{"key":"BFsrep34017_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/ard.56.3.201","volume":"56","author":"S Adami","year":"1997","unstructured":"Adami, S., Fossaluzza, V., Gatti, D., Fracassi, E. & Braga, V. Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann Rheum Dis 56, 201\u2013204 (1997).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep34017_CR39","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/rheumatology\/kes312","volume":"52","author":"M Varenna","year":"2013","unstructured":"Varenna, M. et al. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology (Oxford) 52, 534\u2013542 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep34017_CR40","first-page":"451","volume":"32","author":"M Varenna","year":"2014","unstructured":"Varenna, M., Adami, S. & Sinigaglia, L. Bisphosphonates in Complex Regional Pain syndrome type I: how do they work? Clin Exp Rheumatol 32, 451\u2013454 (2014).","journal-title":"Clin Exp Rheumatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34017","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:47:57Z","timestamp":1672897677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,30]]}},"alternative-id":["BFsrep34017"],"URL":"https:\/\/doi.org\/10.1038\/srep34017","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,30]]},"assertion":[{"value":"5 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34017"}}